BRIEF-Welsbach Technology Metals Acquisition Announces Extension To Business Combination Deadline-March 2024-www.financetom.com

BRIEF-Welsbach Technology Metals Acquisition Announces Extension To Business Combination Deadline

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Welsbach Technology Metals Acquisition Announces Extension To Business Combination Deadline

Jul 5, 2024 7:18 AM

July 5 (Reuters) - Welsbach Technology Metals

Acquisition Corp ( WTMA ):

* WELSBACH TECHNOLOGY METALS ACQUISITION CORP. ( WTMA ) ANNOUNCES

EXTENSION

TO BUSINESS COMBINATION DEADLINE

* WELSBACH TECHNOLOGY METALS ACQUISITION CORP ( WTMA ) - WTMAC

EXTENDS

BUSINESS COMBINATION PERIOD TO JUNE 30, 2025

Source text for Eikon:

Further company coverage:

Previous page： Update: Market Chatter: Kraft Heinz Seeks Sale of Plasmon Infant Food Product Brand Next page： Chimerix Says FDA Grants Priority Review for New Drug Application of Cancer Treatment Dordaviprone; Shares Rise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Market Chatter: Kraft Heinz Seeks Sale of Plasmon Infant Food Product Brand

Feb 18, 2025

10:48 AM EST, 02/18/2025 (MT Newswires) -- (Updates with Houlihan Lokey's response in the fifth paragraph.) Kraft Heinz ( KHC ) is cooperating with Houlihan Lokey to sell its Plasmon infant food product brand, Reuters reported Tuesday, citing two sources close to the matter. Binding offers for the Italy-based business are expected by next month, the report said, citing one...

Chimerix Says FDA Grants Priority Review for New Drug Application of Cancer Treatment Dordaviprone; Shares Rise

Feb 18, 2025

10:53 AM EST, 02/18/2025 (MT Newswires) -- Chimerix ( CMRX ) said Tuesday the US Food and Drug Administration has accepted a new drug application seeking accelerated approval for dordaviprone to treat recurrent H3 K27M-mutant diffuse glioma. The application has been granted priority review and assigned a target action date of Aug. 18, the company said, adding the FDA does...

Guyana, Dominican Republic advance on oil drilling and refining, says president

Feb 18, 2025

GEORGETOWN, Feb 18 (Reuters) - Guyana and the Dominican Republic are making progress on accords for offshore oil and gas exploration and to build a petrochemical plant and possible refinery in the South American country, Dominican President Luis Abinader said on Tuesday. The countries signed a memorandum of understanding in 2023 to work jointly on the energy projects. The Dominican...

BRIEF-Kandal M Venture Limited Says Now Sees U.S. IPO Of Up To 2 Million Class A Ordinary Shares - SEC Filing

Feb 18, 2025

Feb 18 (Reuters) - Kandal M Venture Limited: * KANDAL M VENTURE LIMITED: NOW SEES U.S. IPO OF UP TO 2 MILLION CLASS A ORDINARY SHARES - SEC FILING Source text: ;)) ...